跳至主要内容
临床试验/NCT01087359
NCT01087359已完成4 期

Antiinflammatoric and Antioxidative Effect of Melatonin in Human Endotoxaemia

Herlev Hospital1 个研究点 分布在 1 个国家目标入组 12 人开始时间: 2010年6月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
12
试验地点
1
主要终点
Inflammatoric markers

研究概览

简要总结

This is a double blinded, randomised, crossover study with 12 healthy men between 18 and 40 year. The design is based on 6 days:

  • day 1: On day time administration of LPS.
  • day 2: On night time administration of LPS.
  • day 3: On day time administration of LPS + Placebo.
  • day 4: On day time administration of LPS + melatonin.
  • day 5: On night time administration of LPS + placebo.
  • day 6: On night time administration og LPS + melatonin.

Measuring the inflammatoric and oxidative response of LPS and the effect of melatonin compared to placebo on the endotoxaemia.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Prevention
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 40 Years(Adult)
性别
Male
接受健康志愿者

入选标准

  • Age 18-49 year.
  • No sleepiness disorders.
  • No medication

排除标准

  • Allergia to melatonin
  • Alcohol abuse.

研究组 & 干预措施

LPS day

Experimental

干预措施: Melatonin (Drug)

LPS + melatonin night

Active Comparator

干预措施: Melatonin (Drug)

LPS + placebo night

Placebo Comparator

干预措施: Melatonin (Drug)

LPS + melatonin day

Active Comparator

干预措施: Melatonin (Drug)

LPS + placebo day

Placebo Comparator

干预措施: Melatonin (Drug)

LPS night

Experimental

干预措施: Melatonin (Drug)

结局指标

主要结局

Inflammatoric markers

时间窗: measured before and after the administration of LPS endotoxin.

IL-6 TNF-alpha YKL-40

Oxidative markers

时间窗: measured before and after the administration of LPS endotoxin.

Vit C MDA (malondialdehyde)

次要结局

  • Secondary outcome(constant measurment)

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验